Social aspects of antiretroviral therapy scale-up: Introduction and overview

AIDS

Volumn 21, Issue SUPPL. 5, 2007, Pages

  Hirsch, Jennifer S ^a,b   Parker, Richard G ^a,b,c   Aggleton, Peter ^d  

^a Department of Medicine   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Brazilian Interdisciplinary AIDS Association (ABIA)   (Brazil)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

EDITORIAL; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; SOCIAL ASPECT;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DELIVERY OF HEALTH CARE; HIV INFECTIONS; HUMANS; SOCIAL CONDITIONS;

EID: 37349103838     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000298096.51728.7d     Document Type: Editorial

References (43)

1. WHOHIV/AIDS Programme. Towards universal access by 2010: howWHO is working with countries to scale-up HIV prevention, treatment, care and support. Geneva: World Health Organization; 2006. Available at: http://www.who.int/hiv/toronto2006/towardsuniversalaccess.pdf. Accessed: August 2007.
2. Smith R, Siplon P. Drugs into bodies: AIDS treatment activism. Westport, CT: Praeger; 2006.
3. Friedman S, Mottiar S. A moral to the tale: the Treatment Action Campaign and the politics of HIV/AIDS. A case study for the UKZN project entitled: Globalisation, Marginalisation and New Social Movements in post-Apartheid South Africa. Centre for Policy Studies. University of KwaZulu-Natal; 2004. Available at: http://www.nu.ac.za/ccs/files/ Friedman%20Mottier%20TAC%20Research%20Report%20Short.pdf. Accessed: August 2007.
4. Berkman A, Garcia J, Muñoz-Laboy M, Paiva V, Parker R. A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries. Am J Public Health 2005; 95:1162-1172.
5. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004; 292:224-236.
6. Thirumurthy H, Graff-Zivin J, Goldstein M. The economic impact of AIDS treatment: labor supply in western Kenya. NBER working paper no. 11871. Cambridge, MA: National Bureau of Economic Research; 2005.
7. Blower S, Farmer P. Predicting the public health impact of antiretrovirals: preventing HIV in developing countries. AID Science 2003; 3.
8. Chen L, Evans T, Anand S, Boufford JI, Brown H, Chowdhury M, et al. Human resources for health: overcoming the crisis. Lancet 2004; 364:1984-1990.
9. Pogge T. Human rights and global health: a research program. In: Barry C, Pogge T, editors. Global institutions and responsibilities. Oxford: Blackwell Publishers; 2005. pp. 190-217.
10. Gwatkin DR, Guillot M. The burden of disease among the global poor. Current situation, future trends, and implications for strategy. Washington and Geneva: The World Bank and the Global Forum for Health Research; 1999.
11. Drugs for Neglected Diseases Working Group. Fatal imbalance: the crisis in research and development for drugs for neglected diseases. Geneva: MSF and DNDWG; 2001. Available at: www.msf.org/source/access/2001/fatal/fatal. pdf. Accessed: August 2007.
12. Attaran A. How do patents and economic policies affect access to essential medicines in developing countries? Health Affairs 2004; 23:155-166.
13. Ruxin J, Paluzzi J, Wilson P, Tozan Y, Kruk M, Teklehaimanot A. Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines. Lancet 2005; 365:618-621.
14. Hammer PJ. Differential pricing of essential AIDS drugs: markets, politics and public health. J Intl Econ Law 2002; 5: 883-912.
15. Curran J, Debas H, Anya M, Kelley P, Knobler S, Pray L, editors. Scaling up treatment for the global AIDS pandemic: challenges and opportunities. Washington, DC: The National Academies Press; 2001.
16. Lee JW. Global health improvement and WHO: shaping the future. Lancet 2003; 362:2083-2088.
17. Kim JY, Farmer P. AIDS in 2006 - moving toward one world, one hope? JAMA 2006; 355:645-647.
18. Nguyen VK. Antiretroviral globalism, biopolitics, and therapeutic citizenship. In: One A, Collier S, editors. Global assemblages: technology, politics and ethics as anthropological problems. Malden, MA: Blackwell Publishing; 2005.
19. Nguyen VK. Rethinking adherence and reproduction in the era of expanded use of ART in Africa. In: The social impacts of ART scale-up: developing an interdisciplinary research agenda. New York, NY; sponsored by the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University; 2006.
20. Biehl JG. The activist state: global pharmaceuticals, AIDS, and citizenship in Brazil. Social Text 2004; 22:105-132.
21. Halkitis PN, Shrem MT, Zade DD, Wilton L. The physical emotional and interpersonal impact of HAART: exploring the realities of HIV seropositive individuals on combination therapy. J Health Psychol 2005; 10:345-358.
22. World Health Organization. Treating three million by 2005. Making it happen; the WHO Strategy. Geneva: WHO; 2003.
23. Velasco-Hernandez J, Gershengorn H, Blower S. Could wide-spread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2002; 2:487-493.
24. Barnett T, Whiteside A. AIDS in the twenty-first century. Disease and globalization. New York: Palgrave MacMillan; 2002.
25. Stillman S, Bennett S. Workshop on Monitoring and Evaluating the Health System-Wide Effects of the Global Fund to Fight AIDS, TB and Malaria. Bethesda, Maryland: Partners for Health Reformplus (PHRplus)/Abt Associates; 2003.
26. Kober K, VanDamme W. Scaling up access to antiretroviral treatment in southern Africa: who will do the job? Lancet 2004; 364:103-107.
27. Bennett S, Boerma JT, Brugha R. Scaling up HIV/AIDS evaluation. Lancet 2006; 367:79-82.
28. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med 2000; 50:1599-1605.
29. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDs 2003; 17:169-177.
30. Remien RH, Stirratt MJ, Dolezal C, Dognin JS, Wagner GJ, Carballo-Dieguez A, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS 2005; 19:807-814.
31. Greene JA. An ethnography of nonadherence: culture, poverty, and tuberculosis in urban Bolivia. Culture, Med, Psychiatry 2004; 28:401-425.
32. Castro A. Adherence to antiretroviral therapy: merging the clinical and social course of AIDS. PLoS Med 2005; 2:1217-1221.
33. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr 2002; 31 (Suppl. 3):S98-S102.
34. Paterson D, Swindells S, Mohr J, Brester M, Vergis E, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infections. Ann Intern Med 2000; 133:21-30.
35. International Collaboration on HIV Optimism. HIV treatment optimism among gay men: an international perspective. J Acquir Immune Defic Syndr 2003; 32:545-550.
36. Moatti JP, Prudhomme J, Traore DC, Juillet-Amari A, Akribi HA, Msellati P, et al. Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d'Ivoire. AIDS 2003; 17 (Suppl. 3):S69-S77.
37. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS 2002; 16:775-780.
38. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, Were W, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 2006; 20:85-92.
39. Kerrigan D, Bastos FI, Malta M, Carneiro-da-Cunha C, Pilottob JH, Strathdee SA. The search for social validation and the sexual behavior of people living with HIV in Rio de Janeiro, Brazil: understanding the role of treatment optimism in context. Soc Sci Med 2006; 62:2386-2396.
40. Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001; 358:404-409.
41. Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health 2005; 95:53-59.
42. Nguyen VK. Uses and pleasures: sexual modernity, HIV/AIDS, and confessional technologies in a West African metropolis. In: Adams V, Pigg SL, editors. Sex and development: science, sexuality, and morality in global perspective. Durham, North Carolina: Duke University Press; 2005. pp. 245-268.
43. Graff-Zivin J, Thirumurthy H, Goldstein M. AIDS treatment and intrahousehold resource allocations: children's nutrition and schooling in Kenya. NBER Working Paper no. 12689. Cambridge, MA: National Bureau of Economic Research; 2006.